Stalk us here
Powered by Fresh Ideas

Zevia secures $20 million investment to support strategic reset

Source: www.just-drinks.com
EN 中文 DE FR عربى
U.S. soft-drinks company Zevia has announced a $20 million investment deal with GP Investments. The agreement involves issuing convertible preferred stock as part of a business strategy overhaul. This move follows recommendations from a strategic review by Piper Sandler.
Zevia secures $20 million investment to support strategic reset

Zevia, a U.S. company specializing in zero-sugar soft drinks, has finalized a $20 million investment deal with GP Investments. The transaction involves the issuance of convertible preferred stock, marking a significant step in Zevia's planned strategic reset. This follows a thorough review by Piper Sandler, which identified the capital infusion as essential for enhancing shareholder value.

In recent months, Zevia faced pressure from activist investor Kanen Wealth Management, which holds a 4% stake in the company. Kanen advocated for a review of Zevia's strategic options, including the possibility of a sale, arguing that the company had not effectively leveraged the soda industry's growth, despite its comprehensive national distribution and two decades of brand presence.

Newly appointed CEO Alexandre Ruberti, who took over in June, described the investment deal as a crucial milestone that would drive the company's growth agenda. Zevia plans to allocate the funds toward product innovation, digital marketing initiatives targeting creators and micro-influencers, and implementing a hybrid go-to-market strategy to boost market penetration. Additionally, Zevia intends to expand into other high-growth segments of the health-conscious beverage market.

As part of the investment agreement, GP Investments will assign a director to Zevia's board, indicating an active role in the company's future strategic direction.

In conjunction with the investment announcement, Zevia has revised its sales projections for the upcoming third quarter. The company forecasts net sales to reach approximately $48 million, up from a previous estimate of $44 million to $46 million. The anticipated adjusted EBITDA losses have also been narrowed to between $900,000 and $1 million, a change from an earlier forecasted loss range of $3 million to $3.5 million. Zevia is scheduled to release its third-quarter results on November 4.